Solana Co (HSDT) is a company operating both a medical device business and a Solana cryptocurrency treasury reserve strategy, as disclosed in its 10-K filed March 31, 2026. The company holds Solana digital assets as a treasury reserve and references regulatory frameworks applicable to medical devices, including FDA clearance pathways such as 510(k), de novo, and PMA approval processes. The medical device operations are subject to federal healthcare regulations including the Anti-Kickback Statute, the Physician Payment Sunshine Act, and oversight by the Centers for Medicare and Medicaid Services. The Solana treasury reserve business model exposes the company to digital asset regulatory risk, potential validator operations, and smart contract vulnerabilities. As of March 20, 2026, there were approximately 41 holders of record of Class A common stock. The company has never paid a cash dividend on its Class A common stock and has no current plans to do so, retaining any earnings for business use.

Revenue model

The filing excerpts do not specify discrete revenue streams, segment figures, or percentage breakdowns. The company operates a Solana digital asset treasury reserve and a medical device business subject to FDA regulatory approval, but specific revenue amounts or monetization mechanisms are not disclosed in the available excerpts.

Products and services

Medical devices requiring FDA clearance or approval (510(k), de novo, PMA pathways); Solana digital asset treasury reserve holdings; potential future validator operations on the Solana blockchain network.

Customers and end markets

The medical device business serves healthcare settings with products reimbursable under Medicare, Medicaid, and the Children's Health Insurance Program. Relevant care providers include physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, certified nurse midwives, and teaching hospitals, as referenced under the Physician Payment Sunshine Act disclosures in the 10-K filed March 31, 2026.

Value-chain role

Medical device manufacturer subject to FDA regulatory oversight; digital asset treasury holder with disclosed interest in potential Solana validator operations.

Geographic exposure

The filing references U.S. federal and state regulatory regimes as the primary operating environment. Data transfer compliance obligations under EEA, UK, and U.S. frameworks are noted, suggesting some cross-border data activity, but specific international revenue or operational geography is not disclosed in the available excerpts.

Source: SEC 10-K, filed 2026-03-31

Industry: Finance Services Peers: Abbott Laboratories BRAIN SCIENTIFIC INC. SINTX Technologies Inc NANOMIX Corp Avinger Inc Dynatronics Corp HeartSciences Inc Myomo Inc Catheter Precision Inc